i3 Drug Safety’s industry-renowned scientists, researchers, and associated professionals have
published numerous articles in peer-reviewed journals and given acclaimed presentations at
conferences worldwide.
| |
|
Authors:
Brown JS, Moore KM, Braun MM, Ziyadeh N, Chan KA, Lee GM, Kulldorff M
Title:
Active influenza vaccine safety surveillance: potential within a healthcare claims environment.
Publication:
Medical Care. 47(12):1251-1257, December 2009.
|
|
Authors:
Ziyadeh N, McAfee AT, Koro C, Landon J
Title:
Thiazolidinediones and Coronary Heart Disease in a U.S. health insurance database.
Publication:
Clinical Therapeutics 2009
|
|
Authors:
Holick CN, Turnbull BR, Jones ME, Chaudhry S, Bangs ME, Seeger JD.
Title:
Atomoxetine and cerebrovascular outcomes in adults.
Publication:
Journal of Clinical Psychopharmacology. 29(5):453-460, October 2009.
|
|
Authors:
Loughlin J, Wang F, El Khoury A, Mast TC, Doherty M,
Title:
Letter to the Editor: Adherence to the pentavalent rotavirus vaccine recommended administration schedule in the United States: 2006-2007.
Publication:
Pediatric Infectious Disease Journal. 2009:28(7):667-668.
|
|
Authors:
Schneeweiss S, Doherty M, Zhu S, Funch D, Schlienger RG, Fernandez-Vidaurre C, Seeger JD.
Title:
Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
Publication:
Dermatology. 2009;219:7-21.
|
|
Authors:
Dore DD, Seeger JD, Chan KA
Title:
Use of a Claims-Based Active Drug Safety Surveillance System to Assess the Risk of Acute Pancreatitis with Exenatide or Sitagliptin Compared to Metformin or Glyburide.
Publication:
Current Medical Research and Opinion. 2009;25(4):1019-1027.
|
|
Authors:
Velentgas P, Bohn RL, Brown JS, Chan KA, Gladowski P, Holick CN, Kramer JM, Nakasato C, Spettell CM, Walker AM, Zhang F, Pla
Title:
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.
Publication:
Pharmacoepidemiology and Drug Safety 2008; 17(12):1226-34.
|
|
Authors:
McAfee AT, Holdridge KC, Johannes CB, Hornbuckle K, Walker AM.
Title:
The effect of pharmacotherapy for attention-deficit/hyperactivity disorder on risk of seizure in pediatric patients.
Publication:
Current Drug Safety. 2008; 3: 123-131.
|
|
Authors:
Loughlin J, Seeger JD, Eng PM, Foegh M, Clifford, CR, Cutone J, Walker AM
Title:
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Publication:
Contraception 2008;78:377-83.
|
|
Authors:
Schneeweiss S, Seeger JD, Landon J, Walker AM
Title:
Aprotinin during coronary-artery bypass grafting and risk of death.
Publication:
New England Journal of Medicine 2008;358:771-83.
|
View
a complete list of peer-reviewed scientific publications from i3 Drug Safety
| Conference/Event - Location |
Date |
Presenter |
Title/Topic |
Type |
9th Annual DIA Conference on Contemporary Pharmacovigilance and Risk Management Strategies
Washington, DC |
Jan-10 |
Andy McAfee |
Applied Epidemiology Techniques for Pharmacovigilance Risk Management |
Tutorial |
ACPE (Asian Conference on Pharmacoepidemiology)
Tainan, TW |
Oct-09 |
Arnold Chan |
Introduction to Pharmacoepidemiology |
Presentation |
| Arnold Chan |
Pharmacoepidemiology Methods |
Presentation |
| Arnold Chan |
Using database in pharmacoepidemiologic research: ethical concern, data mining and validation |
Presentation |
5th JMDC Medical Data Seminar
Tokyo, JP |
Oct-09 |
Arnold Chan |
Use of Health Insurance Claims data in Pharmaceutical Industry |
Presentation |
NESUG
Burlington, VT |
Sep-09 |
Rob Gately |
Incidence-Density Sampling: Alternative Programming Approaches to Achieve the Same End |
Oral presentation |
ISPE - International Conference on Pharmacoepidemiology
Providence, RI |
Aug-09 |
Andrew McAfee |
Introduction to Pharmacoepidemiology |
Workshop presentation |
| David Dore |
Extended Results on the Risk of Venous Thromboembolism (VTE), Myocardial Infarction (MI), and Stroke in Users of Transdermal Norelgestromin/Ethinyl Estradiol (patch) |
Oral Presentation |
| Jeanne Loughlin |
No Evidence for Association of Tegaserod with Adverse Cardiovascular Ischemic Events |
Oral Presentation |
| Florence Wang |
Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United States: A Claims-Based Analysis |
Oral Presentation |
| Najat Ziyadeh |
Effect of Extended Mortality Ascertainment in a Cohort Study of the Risk of Cancer in Regranex (Becaplermin) Users and Matched Comparators |
Oral Presentation |
| Jeanne Loughlin |
A Post-Marketing Surveillance Program for Pentavalent Rotavirus Vaccine |
Oral Presentation |
| Arnold Chan |
Workshop: Automated Data Sources for Pharmacoepidemiology in Asia-Pacific Region: Updates and Perspectives |
Workshop presentation |
| Kandace Amend |
Characteristics of Patients with DME, RVO, and Uveitis |
Poster |
| Wendy Carman |
Factors Associated with Changes in Management of Benign Prostatic Hyperplasia: Longitudinal Data from the BPH Registry |
Poster |
| Wendy Carman |
Longitudinal Changes in Lower Urinary Tract Symptoms in Men Managed for Benign Prostatic Hyperplasia |
Poster |
| David Dore |
Active Safety Surveillance of the Risk of Acute Pancreatitis (AP) Associated with Exenatide or Sitagliptin Compared to Metformin or Glyburide |
Poster |
| David Dore |
Enhanced Oncology Applications of Health Insurance Claims Data through Clinical Data Linkage |
Poster |
| John Seeger |
Hepatic Events in Duloxetine Users Compared to Other Depressed and Non-Depressed Subjects |
Poster |
| John Seeger |
Cardiovascular Events in Duloxetine Users Compared to Other Depressed and Non-Depressed Subjects |
Poster |
| David Dore |
Positive Predictive Value (PPV) of Commercial Health Insurance Claims Data for Identifying Acute Pancreatitis (AP) in Patients with Diabetes Mellitus (DM) |
Oral presentation |
| Cheryl Enger |
Risk of Hematological Malignancy among Persons with Chronic Idiopathic Thrombocytopenia Purpura |
Poster |
| Jeanne Loughlin |
No Evidence for Association of Tegaserod with Suicide-Related Outcomes |
Poster |
| David Dore |
Incidence of Acute Pancreatitis in Exenatide Initiators Compared to Other Antidiabetic Drug Initiators: A Retrospective Cohort Study |
Oral presentation |
| Kandace Amend |
Trends in LABA Prescription Patterns |
Poster |
| David Dore |
Medical Record Abstraction to Supplement Covariate Data in Health Insurance Claims: The Case of Diabetes and Acute Pancreatitis (AP) |
Poster |
| Cheryl Enger |
Risk of Thromboembolic Events among Persons with Chronic Idiopathic Thrombocytopenia Purpura |
Poster |
| John Seeger |
Atomoxetine and Cerebrovascular Outcomes in Adults |
Poster |
| Jeanne Loughlin |
Adherence to the Pentavalent Rotavirus Vaccine Dosing Schedule in the U.S.: 2006-2007 |
Poster |
ISPOR
Orlando, FL |
May-09 |
John Seeger |
Propensity score workshop |
Presentation |
World Drug Safety Congress
Washington, DC |
Apr-09 |
Arnold Chan |
Prospective monitoring beyond spontaneous reporting |
Presentation |
SAWC - Seminars in advanced wound care
Dallas, TX |
Apr-09 |
Arnold Chan |
Becaplermin and Cancer Safety |
Presentation |
ISPE midyear
Stockholm, SE |
Apr-09 |
John Seeger |
Time-varying propensity scores |
Presentation |
CBI Drug Safety Forum
Arlington, VA |
Mar-09 |
Arnold Chan |
Medical product safety surveillance |
Presentation |
5th China Shanghai International Conference Pharmacoepidemiology and Clinical Drug Rational Use
Xiamen, CN |
Mar-09 |
Arnold Chan |
Real Life Drug Studies |
Presentation |
PMDA (Pharmaceuticals and Medical Device Agency)
Tokyo, JP |
Feb-09 |
Arnold Chan |
Medical product safety surveillance |
Presentation | |
|
|
